Cargando…

Clonality of circulating tumor cells in breast cancer brain metastasis patients

BACKGROUND: The incidence of brain metastases in breast cancer (BCBM) patients is increasing. These patients have a very poor prognosis, and therefore, identification of blood-based biomarkers, such as circulating tumor cells (CTCs), and understanding the genomic heterogeneity could help to personal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riebensahm, Carlotta, Joosse, Simon A., Mohme, Malte, Hanssen, Annkathrin, Matschke, Jakob, Goy, Yvonne, Witzel, Isabell, Lamszus, Katrin, Kropidlowski, Jolanthe, Petersen, Cordula, Kolb-Kokocinski, Anja, Sauer, Sascha, Borgmann, Kerstin, Glatzel, Markus, Müller, Volkmar, Westphal, Manfred, Riethdorf, Sabine, Pantel, Klaus, Wikman, Harriet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720990/ https://www.ncbi.nlm.nih.gov/pubmed/31481116 http://dx.doi.org/10.1186/s13058-019-1184-2

Ejemplares similares

Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic Disease
por: Hanssen, Annkathrin, et al.
Publicado: (2018)

EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients
por: Scharpenseel, Heather, et al.
Publicado: (2019)

Clinical Relevance of Loss of 11p15 in Primary and Metastatic Breast Cancer: Association with Loss of PRKCDBP Expression in Brain Metastases
por: Wikman, Harriet, et al.
Publicado: (2012)

Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay
por: Belloum, Yassine, et al.
Publicado: (2020)

Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients
por: Wikman, Harriet, et al.
Publicado: (2014)

Circulating tumor cells and extracellular vesicles as liquid biopsy markers in neuro-oncology: prospects and limitations
por: Westphal,, Manfred, et al.
Publicado: (2022)

Circulating Tumour Cell Release after Cement Augmentation of Vertebral Metastases
por: Mohme, Malte, et al.
Publicado: (2017)

Molecular profiling of an osseous metastasis in glioblastoma during checkpoint inhibition: potential mechanisms of immune escape
por: Mohme, Malte, et al.
Publicado: (2020)

Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer
por: Hanssen, Annkathrin, et al.
Publicado: (2015)

PTEN mediates the cross talk between breast and glial cells in brain metastases leading to rapid disease progression
por: Hohensee, Ina, et al.
Publicado: (2016)

Breast cancer brain metastases: biology and new clinical perspectives
por: Witzel, Isabell, et al.
Publicado: (2016)

CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis
por: Loreth, Desiree, et al.
Publicado: (2021)

Relevance of PTEN loss in brain metastasis formation in breast cancer patients
por: Wikman, Harriet, et al.
Publicado: (2012)

Combined Liquid Biopsy Methylation Analysis of CADM1 and MAL in Cervical Cancer Patients
por: Leffers, Markus, et al.
Publicado: (2022)

Clinical determinants impacting overall survival of patients with operable brain metastases from non-small cell lung cancer
por: Piffko, Andras, et al.
Publicado: (2022)

Circulating Cancer Associated Macrophage-like Cells as a Potential New Prognostic Marker in Pancreatic Ductal Adenocarcinoma
por: Nitschke, Christine, et al.
Publicado: (2022)

Characterization of different CTC subpopulations in non-small cell lung cancer
por: Hanssen, Annkathrin, et al.
Publicado: (2016)

Characterization of RARRES1 Expression on Circulating Tumor Cells as Unfavorable Prognostic Marker in Resected Pancreatic Ductal Adenocarcinoma Patients
por: Nitschke, Christine, et al.
Publicado: (2022)

Detection and Characterization of Estrogen Receptor α Expression of Circulating Tumor Cells as a Prognostic Marker
por: Ningsi, Retno, et al.
Publicado: (2022)

PATH-05 Challenge and clinical relevance of a non-matching classifier output in genome-wide DNA methylation analysis for CNS neoplasms in pediatric and adolescent patients
por: Drexler, Richard, et al.
Publicado: (2022)

Comparative evaluation of PD‐L1 expression in cytology imprints, circulating tumour cells and tumour tissue in non‐small cell lung cancer patients
por: Abdo, Mustafa, et al.
Publicado: (2023)

Stromal expression of ALDH1 in human breast carcinomas indicates reduced tumor progression
por: Bednarz-Knoll, Natalia, et al.
Publicado: (2015)

Comparative study of whole genome amplification and next generation sequencing performance of single cancer cells
por: Babayan, Anna, et al.
Publicado: (2016)

Chimeric Antigen Receptor T Cells in Glioblastoma—Current Concepts and Promising Future
por: Kringel, Rebecca, et al.
Publicado: (2023)

The role of the desmosomal protein desmocollin 2 in tumour progression in triple negative breast cancer patients
por: Reimer, Francesca, et al.
Publicado: (2023)

Loss of 4q21.23-22.1 Is a Prognostic Marker for Disease Free and Overall Survival in Non-Small Cell Lung Cancer
por: Uzunoglu, Faik G., et al.
Publicado: (2014)

Evaluation of serum epidermal growth factor receptor (EGFR) in correlation to circulating tumor cells in patients with metastatic breast cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2017)

Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung Cancer Patients
por: van der Leest, Paul, et al.
Publicado: (2023)

Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients
por: Eichelser, Corinna, et al.
Publicado: (2014)

The histone H2B ubiquitin ligase RNF40 is required for HER2-driven mammary tumorigenesis
por: Wegwitz, Florian, et al.
Publicado: (2020)

Emerging Insights into Keratin 16 Expression during Metastatic Progression of Breast Cancer
por: Elazezy, Maha, et al.
Publicado: (2021)

Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2018)

The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2019)

Improved Detection of Circulating Tumor Cells in Metastatic Colorectal Cancer by the Combination of the CellSearch(®) System and the AdnaTest(®)
por: Gorges, Tobias M., et al.
Publicado: (2016)

Inverse Perfusion Requirements of Supra- and Infratentorial Brain Metastases Formation
por: Schneider, Tanja, et al.
Publicado: (2018)

Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
por: Keller, Laura, et al.
Publicado: (2020)

Clinical applications and utility of cell-free DNA-based liquid biopsy analyses in cervical cancer and its precursor lesions
por: Herbst, Johanna, et al.
Publicado: (2022)

Heterogeneity of Estrogen Receptor Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients
por: Babayan, Anna, et al.
Publicado: (2013)

Pre-Analytical and Analytical Variables of Label-Independent Enrichment and Automated Detection of Circulating Tumor Cells in Cancer Patients
por: Koch, Claudia, et al.
Publicado: (2020)

Exploiting Chromosomal Instability of PTEN-Deficient Triple-Negative Breast Cancer Cell Lines for the Sensitization Against PARP1 Inhibition in a Replication-Dependent Manner
por: Rieckhoff, Johanna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hk04520apbgtqemgepfkb1am17